Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for

Volume 3, Issue 5, Page 1 (May 2008)

1 of 38 View next.

Pioglitazone Slows Atherosclerosis

PATRICE WENDLING (Chicago Bureau)

CHICAGO — Treatment of type 2 diabetes with pioglitazone resulted in significant prevention of coronary atherosclerosis progression, compared with glimepiride, in a prospective, randomized study of 543 patients.

PII: S1558-0164(08)70163-9

doi:10.1016/S1558-0164(08)70163-9

1 of 38 View next.